Industry: Medical Devices & Consumables
Published Date: 2024-10-01
Pages: 116 Pages
Report ld: 3335728
Request Sample
Customized Report
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
The global Human Serum and Plasma revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Human Serum and Plasma revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Human Serum and Plasma market, also covers the segmentation data of other regions in regional level and county level.
The global key players of Human Serum and Plasma include Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio, etc. The global five biggest players hold a share of % in 2023.
Human Serum and Plasma market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Human Serum and Plasma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Human Serum and Plasma market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Human Serum and Plasma definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Human Serum and Plasma companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Human Serum and Plasma in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Serum and Plasma sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Human Serum and Plasma Product Introduction
1.2 Global Human Serum and Plasma Outlook 2019 VS 2023 VS 2030
1.2.1 Global Human Serum and Plasma Sales in US$ Million for the Year 2019-2030
1.2.2 Global Human Serum and Plasma Sales in Volume for the Year 2019-2030
1.3 United States Human Serum and Plasma Outlook 2019 VS 2023 VS 2030
1.3.1 United States Human Serum and Plasma Sales in US$ Million for the Year 2019-2030
1.3.2 United States Human Serum and Plasma Sales in Volume for the Year 2019-2030
1.4 Human Serum and Plasma Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Human Serum and Plasma in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Human Serum and Plasma Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Human Serum and Plasma Market Dynamics
1.5.1 Human Serum and Plasma Industry Trends
1.5.2 Human Serum and Plasma Market Drivers
1.5.3 Human Serum and Plasma Market Challenges
1.5.4 Human Serum and Plasma Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Human Serum and Plasma by Type
2.1 Human Serum and Plasma Market by Type
2.1.1 Fresh Human Serum and Plasma
2.1.2 Frozen Human Serum and Plasma
2.2 Global Human Serum and Plasma Market Size by Type
2.2.1 Global Human Serum and Plasma Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Human Serum and Plasma Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Human Serum and Plasma Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Human Serum and Plasma Market Size by Type
2.3.1 United States Human Serum and Plasma Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Human Serum and Plasma Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Human Serum and Plasma Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Human Serum and Plasma by Application
3.1 Human Serum and Plasma Market by Application
3.1.1 In Vitro Diagnostics
3.1.2 Vaccines and Antibodies
3.1.3 Cell Culture
3.1.4 Clinical Research
3.1.5 Others
3.2 Global Human Serum and Plasma Market Size by Application
3.2.1 Global Human Serum and Plasma Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Human Serum and Plasma Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Human Serum and Plasma Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Human Serum and Plasma Market Size by Application
3.3.1 United States Human Serum and Plasma Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Human Serum and Plasma Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Human Serum and Plasma Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Human Serum and Plasma Competitor Landscape by Company
4.1 Global Human Serum and Plasma Market Size by Company
4.1.1 Global Key Manufacturers of Human Serum and Plasma, Ranked by Revenue (2023)
4.1.2 Global Human Serum and Plasma Revenue by Manufacturer (2019-2024)
4.1.3 Global Human Serum and Plasma Sales by Manufacturer (2019-2024)
4.1.4 Global Human Serum and Plasma Price by Manufacturer (2019-2024)
4.2 Global Human Serum and Plasma Concentration Ratio (CR)
4.2.1 Human Serum and Plasma Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Serum and Plasma in 2023
4.2.3 Global Human Serum and Plasma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Human Serum and Plasma, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Human Serum and Plasma, Product Offered and Application
4.5 Global Key Manufacturers of Human Serum and Plasma, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Human Serum and Plasma Market Size by Company
4.7.1 Key Players of Human Serum and Plasma in United States, Ranked by Revenue (2023)
4.7.2 United States Human Serum and Plasma Revenue by Players (2019-2024)
4.7.3 United States Human Serum and Plasma Sales by Players (2019-2024)
5 Global Human Serum and Plasma Market Size by Region
5.1 Global Human Serum and Plasma Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Human Serum and Plasma Market Size in Volume by Region (2019-2030)
5.2.1 Global Human Serum and Plasma Sales in Volume by Region: 2019-2024
5.2.2 Global Human Serum and Plasma Sales in Volume Forecast by Region (2025-2030)
5.3 Global Human Serum and Plasma Market Size in Value by Region (2019-2030)
5.3.1 Global Human Serum and Plasma Sales in Value by Region: 2019-2024
5.3.2 Global Human Serum and Plasma Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Human Serum and Plasma Market Size YoY Growth 2019-2030
6.2 Americas Human Serum and Plasma Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Human Serum and Plasma Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Human Serum and Plasma Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Human Serum and Plasma Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Human Serum and Plasma Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Human Serum and Plasma Market Size YoY Growth 2019-2030
7.2 EMEA Human Serum and Plasma Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Human Serum and Plasma Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Human Serum and Plasma Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Human Serum and Plasma Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Human Serum and Plasma Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Human Serum and Plasma Market Size YoY Growth 2019-2030
8.2 China Human Serum and Plasma Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Human Serum and Plasma Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Human Serum and Plasma Market Size YoY Growth 2019-2030
9.2 APAC Human Serum and Plasma Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Human Serum and Plasma Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Human Serum and Plasma Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Human Serum and Plasma Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Human Serum and Plasma Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Akron
10.1.1 Akron Company Information
10.1.2 Akron Description and Business Overview
10.1.3 Akron Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Akron Human Serum and Plasma Products Offered
10.1.5 Akron Recent Development
10.2 Baxter
10.2.1 Baxter Company Information
10.2.2 Baxter Description and Business Overview
10.2.3 Baxter Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Baxter Human Serum and Plasma Products Offered
10.2.5 Baxter Recent Development
10.3 Cytiva
10.3.1 Cytiva Company Information
10.3.2 Cytiva Description and Business Overview
10.3.3 Cytiva Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Cytiva Human Serum and Plasma Products Offered
10.3.5 Cytiva Recent Development
10.4 Merck Millipore
10.4.1 Merck Millipore Company Information
10.4.2 Merck Millipore Description and Business Overview
10.4.3 Merck Millipore Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.4.4 Merck Millipore Human Serum and Plasma Products Offered
10.4.5 Merck Millipore Recent Development
10.5 Monobind
10.5.1 Monobind Company Information
10.5.2 Monobind Description and Business Overview
10.5.3 Monobind Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.5.4 Monobind Human Serum and Plasma Products Offered
10.5.5 Monobind Recent Development
10.6 SeraCare
10.6.1 SeraCare Company Information
10.6.2 SeraCare Description and Business Overview
10.6.3 SeraCare Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.6.4 SeraCare Human Serum and Plasma Products Offered
10.6.5 SeraCare Recent Development
10.7 TCS Biosciences Ltd
10.7.1 TCS Biosciences Ltd Company Information
10.7.2 TCS Biosciences Ltd Description and Business Overview
10.7.3 TCS Biosciences Ltd Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.7.4 TCS Biosciences Ltd Human Serum and Plasma Products Offered
10.7.5 TCS Biosciences Ltd Recent Development
10.8 Thermo Fisher
10.8.1 Thermo Fisher Company Information
10.8.2 Thermo Fisher Description and Business Overview
10.8.3 Thermo Fisher Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.8.4 Thermo Fisher Human Serum and Plasma Products Offered
10.8.5 Thermo Fisher Recent Development
10.9 Trina Bioreactives
10.9.1 Trina Bioreactives Company Information
10.9.2 Trina Bioreactives Description and Business Overview
10.9.3 Trina Bioreactives Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.9.4 Trina Bioreactives Human Serum and Plasma Products Offered
10.9.5 Trina Bioreactives Recent Development
10.10 Zen-Bio
10.10.1 Zen-Bio Company Information
10.10.2 Zen-Bio Description and Business Overview
10.10.3 Zen-Bio Human Serum and Plasma Sales, Revenue and Gross Margin (2019-2024)
10.10.4 Zen-Bio Human Serum and Plasma Products Offered
10.10.5 Zen-Bio Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Human Serum and Plasma Industry Chain Analysis
11.2 Human Serum and Plasma Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Human Serum and Plasma Production Mode & Process
11.4 Human Serum and Plasma Sales and Marketing
11.4.1 Human Serum and Plasma Sales Channels
11.4.2 Human Serum and Plasma Distributors
11.5 Human Serum and Plasma Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human Serum and Plasma market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 141
USD 4900.00
(Single User License)
The global Human Serum and Plasma market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 76
USD 4250.00
(Single User License)
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 101
USD 3950.00
(Single User License)
The global Human Serum and Plasma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 116
USD 2900.00
(Single User License)
The global Human Serum and Plasma market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 144
USD 4900.00
(Single User License)
The global Human Serum and Plasma market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 107
USD 3950.00
(Single User License)
The global market for Human Serum and Plasma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 86
USD 2900.00
(Single User License)
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published Date: 2024-10-01
Pages: 137
USD 4900.00
(Single User License)
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published Date: 2024-10-01
Pages: 83
USD 2900.00
(Single User License)
The global Human Serum and Plasma market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 141
The global Human Serum and Plasma market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 76
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 101
The global Human Serum and Plasma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 116
The global Human Serum and Plasma market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 144
The global Human Serum and Plasma market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 107
The global market for Human Serum and Plasma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 86
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published: 2024-10-01
Pages: 137
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published: 2024-10-01
Pages: 83
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now